Skip to main content
Equibles

Candriam S.C.A.

Position in VCYT — Veracyte, Inc.

CIK 1537014 STRASSEN, N4
Back to VCYT Full portfolio

Position in VCYT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,928,256
+$42,005 QoQ
Shares Held
134,995
-41.7% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#69
of 367 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCYT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $606,603,850 across 15 Diagnostics & Research names. VCYT ranks #14 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 A
Agilent Technologies, Inc.
 1,352,228 $179,616,445
2 TMO
Thermo Fisher Scientific Inc.
 347,426 $174,185,499
3 DHR
Danaher Corp /De/
 180,852 $34,448,688
4 MTD
Mettler Toledo International Inc/
 22,037 $28,152,487
5 IQV
Iqvia Holdings Inc.
 139,445 $26,943,562
6 DGX
Quest Diagnostics Inc
 120,238 $25,484,444
7 ILMN
Illumina, Inc.
 138,268 $24,311,662
8 CRL
Charles River Laboratories International, Inc.
 105,152 $23,847,422

All Filings in VCYT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,928,256 134,995
2024-09-30 $7,886,251 231,676
2024-06-30 $14,539,204 670,937
2024-03-31 $14,867,963 670,937
2023-12-31 $16,806,739 610,932
2023-06-30 $15,305,585 600,926
2023-03-31 $13,873,855 622,146
2022-12-31 $14,288,923 602,146
2022-09-30 $6,285,805 378,663
2022-06-30 $7,535,393 378,663
2022-03-31 $10,439,738 378,663
2020-09-30 $6,582,310 202,595
2020-06-30 $5,413,488 209,015
2020-03-31 $3,972,837 163,424